AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15724045
Drug: Oral placebos
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebos
Trial: 11819193
Drug: Double caudal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double caudal injection versus single caudal injection
Trial: 7574780
Drug: ACR‐CH (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACR‐CH (10 mg/person local injection)
Trial: 7574780
Drug: ACR aqueous
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACR aqueous solution (10 mg/person local injection)
Trial: 30060248
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of CKA up to 600 mg in humans
Trial: 30060248
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of CKA in rats
Trial: 23081753
Drug: BOC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BOC plus PegIFN/RBV using response-guided therapy (BOC/RGT)
Trial: 23081753
Drug: Management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management of anemia (EPO without RBV dose reduction)
Trial: 23081753
Drug: Management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management of anemia (RBV dose reduction without EPO)
Trial: 23081753
Drug: Management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management of anemia (EPO with RBV dose reduction)
Trial: 23081753
Drug: Management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management of anemia (neither RBV dose reduction nor EPO)
Trial: 20846082
Drug: Electronic ASQ
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic ASQ (asthma screening questionnaire) using a tablet computer
Trial: 18992654
Drug: Oral tolvaptan,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tolvaptan, a vasopressin antagonist
Trial: 22829919
Drug: Monthly sulfadoxine-pyrimethamine
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly sulfadoxine-pyrimethamine (SP)
Trial: 18008240
Drug: 2-dose sulfadoxine-pyrimethamine
RxNorm normalized name: Fansidar 500/25 (sulfadoxine / pyrimethamine) Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose sulfadoxine-pyrimethamine (SP)
Trial: 8491007
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg daily)
Trial: 9071199
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg tid)
Trial: 29107036
Drug: BA+CPT (Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BA+CPT (Behavioral Activation + Cognitive Processing Therapy)
Trial: 30554135
Drug: CPT (Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT (Cognitive Processing Therapy)
Trial: 27087678
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (OT) integrated with a self-administered stretching program
Trial: 24886671
Drug: FOLFOX chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX chemotherapy strategy
Trial: 8868311
Drug: Vehicle (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (50 ml isotonic saline)
Trial: 1364939
Drug: Plain tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain tablets
Trial: 4019267
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ascorbic acid three times daily during meals
Trial: 31806216
Drug: Dabigatran dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran dual therapy (110 mg twice daily)
Trial: 31806216
Drug: Dabigatran dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran dual therapy (150 mg twice daily)
Trial: 26516724
Drug: Placebo DISKUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo DISKUS DPI (twice daily)
Trial: 23418668
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate (2250 mg/day)
Trial: 19189275
Drug: Classical massage
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classical massage treatment (bi-weekly 30-min sessions for 5 weeks)
Trial: 17697551
Drug: Radiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy combined with h-R3 (100 mg weekly intravenous infusion during radiotherapy)
Trial: 15133322
Drug: 1.3 mg
RxNorm normalized name: menthol 1.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 mg of beta-cryptoxanthin (free)
Trial: 15133322
Drug: 1.3 mg
RxNorm normalized name: menthol 1.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 mg of beta-cryptoxanthin (esters and free)
Trial: 9163859
Drug: Deflazacort (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort (6 mg deflazacort to 5 mg prednisone ratio)
Trial: 8201735
Drug: S boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S boulardii (1 g/d for 4 weeks) with standard antibiotics
Trial: 8201735
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with standard antibiotics
Trial: 3146765
Drug: Sabeluzole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sabeluzole (10 mg b.i.d. for 7 days)
Trial: 21038021
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (Dexarhinaspray duo and nasal douche)
Trial: 31361303
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy
Trial: 12398148
Drug: Standard preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard preparation plus preoperative preparation with 70% alcohol
Trial: 2610502
Drug: Pirenzepine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (50 mg per dose for 4 doses)
Trial: 2610502
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg per dose for 3 doses)
Trial: 2610502
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (625 mg)
Trial: 12449294
Drug: Three servings
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three servings of yogurt added to daily diet
Trial: 15536601
Drug: Glyburide treatment
RxNorm normalized name: Glyburide
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide treatment
Trial: 27903262
Drug: Test mouthwash
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test mouthwash (0.25 mg/ml green tea and 7.82 mg/ml Salvadora persica L.)
Trial: 18332449
Drug: Icodextrin 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icodextrin 1000 mL
Trial: 18332449
Drug: Icodextrin 2500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icodextrin 2500 mL
Trial: 7880938
Drug: GHRH administration
RxNorm normalized name: GHRH(1-44)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH administration
Trial: 2970203
Drug: Mianserin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (60 mg daily)
Trial: 6407502
Drug: Chlorimipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorimipramine (150 mg daily)
Trial: 30587610
Drug: Placebo moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo moisturizing cream
Trial: 16080808
Drug: ACE inhibitor-perindopril
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor-perindopril (+ diuretic-indapamide)
Trial: 11136842
Drug: Raloxifene (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (higher dose)
Trial: 11136842
Drug: Raloxifene (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (lower dose)
Trial: 23651816
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment; n=22
Trial: 16945045
Drug: TrimSpa (ephedra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TrimSpa (ephedra 15 mg and caffeine 60 mg, 3 times/day for 7 days)
Trial: 11406335
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg peroral ketoprofen
Trial: 11406335
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg peroral ketoprofen
Trial: 11406335
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg topical 2.5% ketoprofen gel
Trial: 7920940
Drug: Mifepristone (RU486)
DrugBank: Mifepristone (DB00834)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mifepristone (RU486) 600 mg
Trial: 25581159
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg) 100 U/mL, subcutaneously, at doses of 0.4-0.8 U/kg for 6-12 days
Trial: 14605997
Drug: Bolus rGLP-1
RxNorm normalized name: rGLP-1
DrugBank: rGLP-1 (DB05433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus rGLP-1 injections at 1.5 nmol/kg
Trial: 14605997
Drug: Continuous rGLP-1
RxNorm normalized name: rGLP-1
DrugBank: rGLP-1 (DB05433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous rGLP-1 infusion at up to 4.5 pmol/kg/min
Trial: 14605997
Drug: Continuous rGLP-1
RxNorm normalized name: rGLP-1
DrugBank: rGLP-1 (DB05433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous rGLP-1 infusion in SU cohort
Trial: 14605997
Drug: rGLP-1 infusions
RxNorm normalized name: rGLP-1
DrugBank: rGLP-1 (DB05433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rGLP-1 infusions
Trial: 10584647
Drug: Twice-daily heparin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily heparin flushes with once-weekly urokinase instillation (group B, n = 53)
Trial: 10584647
Drug: Twice-daily heparin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily heparin flushes (group A, n = 52)
Trial: 9257201
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 25 mg
Trial: 9257201
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 50 mg
Trial: 9257201
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 100 mg
Trial: 8911112
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg x 3 or 8 mg x 4)
Trial: 3053313
Drug: Acarbose (BAY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (BAY g 5421)
Trial: 31179773
Drug: Oral mucoadhesive
RxNorm normalized name: testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mucoadhesive film containing chitosan
Trial: 27912735
Drug: Edmonston-Zagreb measles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb measles vaccine at 4.5 and 9 months (group A)
Trial: 27912735
Drug: Edmonston-Zagreb measles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb measles vaccine at 4.5 months (group A)
Trial: 27912735
Drug: No vaccine
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No vaccine at 4.5 months and Edmonston-Zagreb measles vaccine at 9 months (group B)
Trial: 27912735
Drug: No vaccine
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No vaccine at 4.5 months and Schwarz measles vaccine at 9 months (group C)
Trial: 24040472
Drug: Negatively-charged aerosol
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Negatively-charged aerosol therapy (2 hours per time, twice a day)
Trial: 24040472
Drug: Normal, routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal, routine treatment
Trial: 16809801
Drug: Single-dose ritonavir
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Single-dose ritonavir 100 mg
Trial: 3497039
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tenoxicam
Trial: 7983661
Drug: 500-1000 mg
RxNorm normalized name: ampicillin 1000 MG / sulbactam 500 MG [Unasyn]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-1000 mg naproxen
Trial: 31838180
Drug: Lindioil ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lindioil ointment
Trial: 23327021
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (dexamethasone, acetaminophen codeine, placebo)
Trial: 18760982
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (self-monitoring daily pedometer-determined step count)
Trial: 7762844
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac and IA bupivacaine
Trial: 22166525
Drug: Epirubicin (EPI)
DrugBank: Epirubicin (DB00445)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epirubicin (EPI) 30 mg/30 ml, 29 doses over 24 months
Trial: 22166525
Drug: Pirarubicin (THP)
RxNorm normalized name: pirarubicin
DrugBank: Pirarubicin (DB11616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirarubicin (THP) 30 mg/30 ml, 29 doses over 24 months
Trial: 8349477
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg)
Trial: 31493397
Drug: Subcutaneous mirikizumab
RxNorm normalized name: Mirikizumab
DrugBank: Mirikizumab (DB14910)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous mirikizumab 200 mg every 12 weeks
Trial: 26084944
Drug: Intraocular lens
RxNorm normalized name: lens scale pollen extract
DrugBank: Atriplex lentiformis pollen (DB10760)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraocular lens treatment
Trial: 21955403
Drug: simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin 40 mg/day plus rosiglitazone 4 mg/day
Trial: 21955403
Drug: simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin 40 mg/day plus placebo
Trial: 17125998
Drug: Sufentanil 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 0.75 microg/mL with bupivacaine
Trial: 17125998
Drug: Sufentanil 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 0.75 microg/mL with ropivacaine
Trial: 9797234
Drug: Piperacillin-tazobactam (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam (4.5 g three times a day)
Trial: 9797234
Drug: Imipenem-cilastatin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem-cilastatin (0.5 g four times a day)
Trial: 8457237
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate (MPA) 0.01%, 0.05%, 0.1%, 0.5% ointment
Trial: 8457237
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate (MPA) 0.1% (cream, ointment, fatty ointment)
Trial: 8457237
Drug: Difluocortolone 21-valerate
RxNorm normalized name: diflucortolone valerate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Difluocortolone 21-valerate 0.1% (DFV) ointment
Trial: 31372210
Drug: Conventional Endodontic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Endodontic Treatment (Endo)
Trial: 25179753
Drug: Screening, Assessment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening, Assessment, and Referral to Treatment (SAR)
Trial: 20041428
Drug: Pycnogenol (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (oral and topical)
Trial: 12412822
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray
Trial: 12222660
Drug: PYCNOGENOL chewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PYCNOGENOL chewing gums (5 mg)
Trial: 10381531
Drug: SCF +
RxNorm normalized name: Immunoglobulin scfv-scfv-scfc, anti-(homo sapiens dll3 (delta-like ligand 3)) and anti-(homo sapiens cd3e (cd3 epsilon, leu-4)), monoclonal antibody single chain (scfv)2-scfc, bispecific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCF + G-CSF
Trial: 10381531
Drug: G-CSF +
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF + SCF
Trial: 30701655
Drug: Treatment stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment stimulation (peripheral nerve stimulation)
Trial: 28210811
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health care training (IG)
Trial: 9779099
Drug: Etched (phosphoric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etched (phosphoric acid gel)
Trial: 2698272
Drug: Amineptine (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amineptine (100-200 mg per day)
Trial: 2698272
Drug: Imipramine (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (50-100 mg per day)
Trial: 31084971
Drug: Intraoperative ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative ketamine infusion at a rate of 6 mcg/kg/min for 75 minutes
Trial: 31084971
Drug: Intraoperative ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative ketamine infusion
Trial: 27823944
Drug: Cervical lidocaine-prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical lidocaine-prilocaine (LP) cream
Trial: 26123101
Drug: Bovine milk
RxNorm normalized name: Bovine Milk Plasma
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine milk containing antibodies
Trial: 23731768
Drug: AZD3199 (200,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD3199 (200, 400 or 800 μg o.d.)
Trial: 23731768
Drug: Formoterol (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol (9 μg b.i.d.)
Trial: 19268410
Drug: Cyclosporine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (5 to 6 mg/kg/d)
Trial: 9477980
Drug: Deferral of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferral of photocoagulation in eyes assigned to the Early Treatment Diabetic Retinopathy Study (ETDRS)
Trial: 3673206
Drug: 1 microgram
RxNorm normalized name: Alfacalcidol 1 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 microgram of Pasteur's hepatitis B vaccine
Trial: 27369430
Drug: Amoxicillin (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (first taste)
Trial: 27369430
Drug: Amoxicillin (second
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (second taste)
Trial: 27369430
Drug: Acetaminophen elixir
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen elixir
Trial: 11826230
Drug: Acetaminophen suspension
RxNorm normalized name: PediaCare Children's Flu Plus Acetaminophen Suspension (Bubble Gum)
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen suspension
Trial: 26273191
Drug: Torasemide-PR 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide-PR 10 mg
Trial: 26273191
Drug: Furosemide-IR 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide-IR 40 mg
Trial: 21669380
Drug: Loss of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loss of 2 g/dl Hgb or more
Trial: 19358959
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care plus adjunctive care by a homeopath
Trial: 12740264
Drug: Budesonide/formoterol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (80 micro g/4.5 micro g, bid)
Trial: 12740264
Drug: Budesonide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (200 micro g, bid)
Trial: 9179687
Drug: Preoperative endocrine
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative endocrine therapy (leuprolide and chlormadinone for 3 months)
Trial: 3972658
Drug: 252Cf implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 252Cf implants alone (Group I)
Trial: 17631387
Drug: Diaphragm, lubricant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diaphragm, lubricant gel, and condoms
Trial: 1570380
Drug: Triazolam 0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.50 mg
Trial: 3413202
Drug: Zolpidem 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 20 mg
Trial: 2514430
Drug: Taprostene (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taprostene (25 ng/kg/min intravenously for 6 hours daily on 5 consecutive days)
Trial: 126075
Drug: 0.1% hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% hydrocortisone cream with vasoconstrictor activity
Trial: 126075
Drug: 1.0% Hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0% Hydrocortisone Cream BPC
Trial: 31913519
Drug: ubrogepant 50
RxNorm normalized name: ubrogepant 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ubrogepant 50 mg